Home›Companies›Biotech & Pharma›Vogenx

Vogenx, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 7, 2026·Suggest an edit

About Vogenx

Vogenx is a private company based in Raleigh, North Carolina, incorporated in 2021 in Delaware. It has reported $750,000 raised in one offering on Form D since January 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 10, 2025Jan 7, 2026$750,000of $5.0M target3$250KDebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vogenx's Form D filed Jan 7, 2026.

WW
William Wilkison
Executive officer and director
PP
SD
Steven Delmar
Chief Financial Officer and director
RG
TB
Tim Boris
Director
Also a director at Elucida Oncology.
JG
James Green
Executive officer and director

Sources

  1. SECVogenx, Inc. filing history